Fair Value Measurements (Narrative) (Detail) (USD $) In Thousands, unless otherwise specified	9 Months Ended		1 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Apr. 30, 2014	Mar. 31, 2011	Jun. 30, 2014
Rising Pharmaceuticals Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration at fair value	$ 2,937				$ 5,694
PACK Pharmaceuticals, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration at fair value	4,133				3,797
France Company
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration at fair value	303				413
Foreign exchange contract
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	54,495
Unrealized gains (losses) on hedging activities	(2,517)	75
Interest rate swap | Cash flow hedging
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized loss recorded in accumulated other comprehensive income	439
Interest rate swap | Cash flow hedging | April 30, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	28,000		25,750
Derivative, interest rate			1.63%
Derivative, expiration date			Apr. 30, 2019
Interest rate swap | Cash flow hedging | December 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	$ 4,000			$ 20,000
Derivative, interest rate				1.91%
Derivative, expiration date				Dec. 31, 2015